Here's Why Abbott's a Great Buy Even if COVID Testing Revenue Falls
2/4 14:00
Abbott Laboratories (NYSE: ABT) is a leader in coronavirus testing. Its laboratory tests and rapid tests have brought in billions of dollars in revenue. In the fourth quarter of last year, for example, Abbott generated $2.3 billion from its COVID-19 tests. And the company said de...